08:02:46 EDT Tue 14 May 2024
Enter Symbol
or Name
USA
CA



Britannia Life Sciences Inc
Symbol BLAB
Shares Issued 162,254,339
Close 2023-12-15 C$ 0.07
Market Cap C$ 11,357,804
Recent Sedar Documents

Britannia Life's ADSL establishes U.S. division

2023-12-18 13:14 ET - News Release

Mr. Peter Shippen reports

BRITANNIA ESTABLISHES U.S. CONSUMER PRODUCTS DIVISION

Britannia Life Sciences Inc.'s subsidiary, Advanced Development & Safety Laboratories (ADSL), has established a United States-based division (ADSL USA) to assist companies in navigating the evolving cosmetic regulatory landscape in the U.S. The new division will also allow ADSL to better support its existing global customers in the U.S. market. The launch of ADSL USA underscores Britannia's commitment to expanding its geographic reach and providing enhanced services to cosmetics and consumer products clients globally.

The introduction of the Modernization of Cosmetics Regulation Act (MoCRA) is the most significant expansion of the Food and Drug Administration's authority to regulate cosmetics since the Federal Food, Drug, and Cosmetic (FD&C) Act was passed in 1938. This new law helps ensure the safety of cosmetic products that many consumers use daily, bringing reporting requirements to a similar standard as the European Union and United Kingdom. ADSL, a recognized leader in formulation, testing and overall regulatory compliance for the cosmetics industry, will be the partner of choice for foreign and U.S.-domiciled companies looking to adapt to the new U.S. regulations.

ADSL USA is committed to assisting clients in meeting regulatory requirements, ensuring product safety, timely approvals and market access. The new division will offer a comprehensive suite of services, including responsible person support, product registration and labelling, and product safety reports, specifically tailored to help clients successfully manoeuvre through the regulatory requirements under MoCRA.

"We are excited to be at the forefront of MoCRA compliance, offering our clients unparalleled expertise and support in navigating the regulatory landscape," said Mark Bowes-Cavanagh, chief executive officer of Britannia, global consumer products. "Our services are designed to streamline the compliance process, providing added trust and transparency to our clients and their customers."

About Britannia Life Sciences Inc.

Britannia Life Sciences is a company focused on introducing cutting-edge technologies into the traditional laboratory and regulatory platforms to power data-driven insights to improve the outcomes of its customers. Britannia provides services to the consumer products sector included an integrated suite of services to assist companies along their product development journey. Britannia's services, including product formulations, safety assessments, analytical and microbiological testing, global compliance, and consumer evaluations, are offered to companies ranging from multinationals to start-ups particularly in the cosmetics, food and wellness industries. Britannia also provides geochemical testing and analysis to the natural resources industry through its subsidiary Britannia Mining Solutions. Britannia's head office is located at 120 Adelaide St. West, suite 2400, Toronto, Ont., M5H 1T1.

© 2024 Canjex Publishing Ltd. All rights reserved.